ARCHIVES

Doctor-Patient Conversations At End of Life Associated With Lower Medical Expenses

This article is from The Cancer Letter archive.

Vol. 32 No. 3 | March 27, 2009

Download PDF Visit The Full Archive

Related Articles

Amgen Agrees To Buy Immunex For $16 Billion In Stock And Cash.

January 25, 2002

In Brief: CT Scanning Of The Brain Subject Of Consensus Development Conference; CCI Plans Congress Events

July 10, 1981

In Brief: NCI To Move Todaro’s Lab to FCR; Cinnamyl Anthranilate Was Carciogenic In Bioassay

March 28, 1980

Also: Court Will Reconsider Ruling on Access To Experimental Drugs.

December 1, 2006

NCI Closes Iressa Trial For NSCLC When Data Indicate No Survival Benefit

April 29, 2005

NCI-Approved Clinical Trials Listed For May 2001

June 29, 2001